Patents-Review.com
🔗 Permalink
Assignee profile:

BioMarin Technologies B.V.

City:

Leiden

Country:

Netherlands

Published Applications:

13

Last publication date:

2020-09-17

Patent Grants:

13

Last grant date:

2021-06-15

Top Inventors for applications by BioMarin Technologies B.V.

These are the the leading inventors for applications assigned to BioMarin Technologies B.V.:

Recent patent applications by BioMarin Technologies B.V.

BioMarin Technologies B.V. based in Leiden, NL has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2020-09-17 ✅ Patent 11,034,956 granted on 2021-06-15
US20200291399A1
Chemistry; metallurgy

Oligonucleotide comprising an inosine for treating DMD

 #2 | 2020-07-30 ✅ Patent 11,427,820 granted on 2022-08-30
US20200239886A1
Chemistry; metallurgy

Methods and means for efficient skipping of exon 45 in Duchenne muscular dystrophy pre-mRNA

 #3 | 2019-06-27 ✅ Patent 10,913,946 granted on 2021-02-09
US20190194656A1
Chemistry; metallurgy

RNA modulating oligonucleotides with improved characteristics for the treatment of Duchenne and Becker muscular dystrophy

 #4 | 2019-04-04 ✅ Patent 10,876,114 granted on 2020-12-29
US20190100754A1
Chemistry; metallurgy

Methods and means for efficient skipping of at least one of the following exons of the human Duchenne muscular dystrophy gene: 43, 46, 50-53

 #5 | 2017-07-20 ✅ Patent 10,533,171 granted on 2020-01-14
US20170204414A1
Chemistry; metallurgy

Oligonucleotide comprising an inosine for treating DMD

 #6 | 2017-02-02 ✅ Patent 10,179,912 granted on 2019-01-15
US20170029818A1
Chemistry; metallurgy

RNA modulating oligonucleotides with improved characteristics for the treatment of duchenne and becker muscular dystrophy

 #7 | 2016-02-25 ✅ Patent 10,246,707 granted on 2019-04-02
US20160053262A1
Chemistry; metallurgy

Method for efficient exon (44) skipping in duchenne muscular dystrophy and associated means

 #8 | 2016-02-25 ✅ Patent 9,890,379 granted on 2018-02-13
US20160053254A1
Chemistry; metallurgy

Treatment of genetic disorders associated with DNA repeat instability

 #9 | 2015-06-18 ✅ Patent 9,499,818 granted on 2016-11-22
US20150166996A1
Chemistry; metallurgy

Methods and means for efficient skipping of at least one of the exons 51-53, 55, 57 and 59 of the human duchenne muscular dystrophy gene

 #10 | 2015-05-28 ✅ Patent 9,745,576 granted on 2017-08-29
US20150148404A1
Chemistry; metallurgy

RNA modulating oligonucleotides with improved characteristics for the treatment of neuromuscular disorders

 #11 | 2015-03-12 ✅ Patent 9,528,109 granted on 2016-12-27
US20150073037A1
Chemistry; metallurgy

Methods and means for efficient skipping of exon 45 in duchenne muscular dystrophy pre-mRNA

 #12 | 2012-01-26 ✅ Patent 9,926,557 granted on 2018-03-27
US20120022134A1
Chemistry; metallurgy

Methods and means for efficient skipping of exon 45 in Duchenne muscular dystrophy pre-mRNA

 #13 | 2011-12-01 ✅ Patent 9,243,245 granted on 2016-01-26
US20110294753A1
Chemistry; metallurgy

Means and methods for counteracting muscle disorders

Also check out BioMarin Technologies B.V.'s (Leiden, Netherlands) applicant profile with 13 patent applications submitted.

AssigneeID:

385316 ⎘